pimicotinib
AssetAlso called ABSK-021-0 FREE BASE ANHYDROUS, ABSK-021-7, ABSK-021 FREE BASE ANHYDROUS, ABSK021-NX
Inhibits CSF1R signaling to reduce tumor-associated macrophage proliferation and survival.
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- CSF1R
- 1
- Indication
- 2
- Trials
- 3
- Developers
Indications
1Tenosynovial giant cell tumor
Phase 3, businesswire.com, Oct 26, 2026
In the full profile
- Target and mechanism1
- Owner and partners3
- Trials2
- Evidence for its targets1
- Competitors3
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.